Drug Type Recombinant polypeptide, Biosimilar |
Synonyms Nesiritide Recombinant Biosimilar (Suzhou Landing Biopharmaceutical, Inc.), 奈西立肽生物类似药(苏州兰鼎生物制药有限公司), 重组人脑钠素(苏州兰鼎生物制药) |
Target |
Action agonists |
Mechanism NPRA agonists(Natriuretic peptide receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (30 Apr 2025), |
Regulation- |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Heart Failure | China | 30 Apr 2025 |






